切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2019, Vol. 05 ›› Issue (05) : 310 -314. doi: 10.3877/cma.j.issn.2095-9141.2019.05.013

所属专题: 经典病例 经典病例 文献

综述

急性缺血性卒中血管内治疗筛选病例的研究进展
梁星宇1, 徐如祥2,(), 梁春阳2   
  1. 1. 100700 北京市东直门中学
    2. 100700 北京,解放军总医院第七医学中心神经外科
  • 收稿日期:2019-05-18 出版日期:2019-10-15
  • 通信作者: 徐如祥
  • 基金资助:
    首都特色临床医学技术发展研究基金(Z090507017709006); 首都医学发展科研基金(2009-2050)

Recent advance in selecting patients about endovascular treatment of acute ischemic stroke

Xingyu Liang1, Ruxiang Xu2,(), Chunyang Liang2   

  1. 1. Dongzhimen Middle School, Beijing 100700, China
    2. Department of Neurosurgery, Seventh Medical Center of PLA General Hospital, Beijing 100700, China
  • Received:2019-05-18 Published:2019-10-15
  • Corresponding author: Ruxiang Xu
  • About author:
    Corresponding author: Xu Ruxiang, Email:
引用本文:

梁星宇, 徐如祥, 梁春阳. 急性缺血性卒中血管内治疗筛选病例的研究进展[J]. 中华神经创伤外科电子杂志, 2019, 05(05): 310-314.

Xingyu Liang, Ruxiang Xu, Chunyang Liang. Recent advance in selecting patients about endovascular treatment of acute ischemic stroke[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2019, 05(05): 310-314.

急性缺血性卒中发病率呈逐年上升趋势,并且具有很高的致残率和致死率。由于静脉阿替普酶溶栓治疗急性缺血性卒中的局限性,2015年以来5大临床前瞻随机双盲多中心临床研究证实新一代血管再通策略(主要是可回收支架)在大血管闭塞导致的急性缺血性卒中明显优于单独内科治疗,各国脑卒中指南也相应进行更新。本文围绕5大临床研究及欧洲、美国最新指南中关于筛选合适卒中患者进行机械取栓的研究进展综述如下。

The incidence of acute ischemic stroke rises year by year, and has a high disability rate and mortality rate. Due to limitations of intravenous alteplase in the treatment of acute ischemic stroke, five randomized trials have demonstrated the benefit of new-generation endovascular recanalization therapies (primarily stent retrievers) over medical therapy alone among patients with acute ischemic stroke since 2015, and the guidelines with acute ischemic stroke guidelines have updated in many countries. This review focuses on five major clinical studies and the latest guidelines in Europe and the United States on the selection of suitable stroke patients for mechanical thrombectomy. The following is a review of the research progress.

[1]
Emberson J,Lees KR,Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials[J]. Lancet, 2014, 384: 1929-1935.
[2]
Jauch EC,Saver JL,Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2013, 44(3): 870-947.
[3]
Bhatia R,Hill MD,Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action[J]. Stroke, 2010, 41(10): 2254-2258.
[4]
Heldner MR,Zubler C,Mattle HP, et al. National institutes of health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke[J]. Stroke, 2013, 44(4): 1153-1157.
[5]
Christou I,Burgin WS,Alexandrov AV, et al. Arterial status after intravenous TPA therapy for ischaemic stroke. A need for further interventions[J]. Int Angiol, 2001, 200(3): 208-213.
[6]
Lima FO,Furie KL,Silva GS, et al. Prognosis of untreated strokes due to anterior circulation proximal intracranial arterial occlusions detected by use of computed tomography angiography[J]. JAMA Neurol, 2014, 71(2): 151-157.
[7]
Ogawa A,Mori E,Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan[J]. Stroke, 2007, 38(10): 2633-2639.
[8]
Mehta B,Leslie-Mazwi TM,Chandra RV, et al. Assessing variability in neurointerventional practice patterns for acute ischemic stroke[J]. J Neurointerv Surg, 2013, 5 Suppl 1: i52-i57.
[9]
Broderick JP,Palesch YY,Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke[J]. N Engl J Med, 2013, 368(10): 893-903.
[10]
Kidwell CS,Jahan R,Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke[J]. N Engl J Med, 2013, 368(10): 914-923.
[11]
Ciccone A,Valvassori L,Nichelatti M, et al. Endovascular treatment for acute ischemic stroke[J]. N Engl J Med, 2013, 368(10): 904-913.
[12]
Pereira VM,Gralla J,Davalos A, et al. Prospective, multicenter, single-arm study of mechanical thrombectomy using solitaire flow restoration in acute ischemic stroke[J]. Stroke, 2013, 44(10): 2802-2807.
[13]
Zaidat OO,Castonguay AC,Gupta R, et al. North American solitaire stent retriever acute stroke registry: post-marketing revascularization and clinical outcome results[J]. J Neurointerv Surg, 2014, 6(8): 584-588.
[14]
Mokin M,Dumont TM,Veznedaroglu E, et al. Solitaire flow restoration thrombectomy for acute ischemic stroke: retrospective multicenter analysis of early postmarket experience after FDA approval[J]. Neurosurgery, 2013, 73(1): 19-25.
[15]
Dávalos A,Pereira VM,Chapot R, et al. Retrospective multicenter study of solitaire FR for revascularization in the treatment of acute ischemic stroke[J]. Stroke, 2012, 43(10): 2699-2705.
[16]
Saver JL,Jahan R,Levy EI, et al. Solitaire flow restoration device versus the merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial[J]. Lancet, 2012, 380(9849): 1241-1249.
[17]
Berkhemer OA,Fransen PS,Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med, 2015, 372(1): 11-20.
[18]
Goyal M,Demchuk AM,Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med, 2015, 372(11): 1019-1030.
[19]
Saver JL,Goyal M,Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med, 2015, 372(24): 2285-2295.
[20]
Jovin TG,Chamorro A,Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med, 2015, 372(24): 2296-2306.
[21]
Campbell BC,Mitchell PJ,Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med, 2015, 372(11): 1009-1018.
[22]
Nogueira RG,Jadhav AP,Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med, 378(1): 11-21.
[23]
Goyal M,Menon BK,van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials[J]. Lancet, 2016, 387(10029): 1723-1731.
[24]
Wahlgren N,Moreira T,Michel P, et al. Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-karolinska stroke update 2014/2015, supported by ESO, ESMINT, ESNR and EAN[J]. Int J Stroke, 2016, 11(1): 134-147.
[25]
Powers WJ,Rabinstein AA,Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association[J]. Stroke, 2018, 49(3): e46-e110.
[26]
Albers GW,Marks MP,Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med, 2018, 378(8): 708-718.
[27]
Bhogal P,Bücke P,Ganslandt O, et al. Mechanical thrombectomy in patients with M1 occlusion and NIHSS score≤5: a single-centre experience[J]. Stroke Vasc Neurol, 2016, 1(4): 165-171.
[28]
Campbell BC,Hill MD,Rubiera M, et al. Safety and efficacy of solitaire stent thrombectomy: individual patient data meta-analysis of randomized trials[J]. Stroke, 2016, 47(3): 798-806.
[29]
Bracard S,Ducrocq X,Mas JL, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial[J]. Lancet Neurol, 2016, 15(11): 1138-1147.
[30]
Saver JL,Goyal M,van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis[J]. JAMA, 2016, 316(12): 1279-1288.
[1] 尚慧娟, 袁晓冬. 机械取栓术后应用依达拉奉右崁醇对急性缺血性脑卒中预后的改善[J]. 中华神经创伤外科电子杂志, 2023, 09(05): 295-301.
[2] 程飞, 杨辉, 周世玲, 赵航. 静脉溶栓后机械取栓桥接治疗急性大动脉闭塞脑梗死可行性研究[J]. 中华神经创伤外科电子杂志, 2023, 09(03): 149-153.
[3] 陈科春, 吴秋义, 李建, 周寅, 徐周. 基于不同中性粒细胞与淋巴细胞比值探讨机械取栓术后首次CT征象与患者预后的关系[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 215-221.
[4] 徐志嘉, 贾振宇, 赵林波, 刘圣, 施海彬, 曹月洲. 高敏肌钙蛋白T动态变化在晚时间窗内进行血管内治疗的急性缺血性脑卒中患者中的预测价值[J]. 中华介入放射学电子杂志, 2023, 11(01): 42-47.
[5] 陈立洲, 李文会, 朱军, 徐晓露, 曹月洲, 贾振宇, 刘圣, 施海彬. 对比分析抽吸取栓与支架取栓治疗前循环大血管急性栓塞性闭塞的临床疗效[J]. 中华介入放射学电子杂志, 2023, 11(01): 35-41.
[6] 赖和泰, 刘羽, 程光森, 刘永康, 李忠亮, 陆骊工. 39例Surpass Streamline治疗未破裂动脉瘤患者诊疗分析:单中心临床经验[J]. 中华介入放射学电子杂志, 2023, 11(01): 19-24.
[7] 王俊杰, 尹晓亮, 刘二腾, 陆军, 祁鹏, 胡深, 杨希孟, 陈鲲鹏, 张东, 王大明. 机器学习对预测颈内动脉非急性闭塞患者血管内再通术成功的潜在价值[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 464-470.
[8] 孙洪扬, 刘基, 龚字翔, 王广英, 宁召腾, 赵璇, 朱其义, 王贤军. 急性前循环大血管闭塞性轻型卒中血管内治疗的临床预后及手术时机选择[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 445-451.
[9] 袁兴运, 陈万红, 鱼丽萍, 姚力. 以Wallenberg综合征起病的椎动脉颅外段闭塞介入治疗探讨[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 394-399.
[10] 杜小林, 陈鄂, 康俊龙, 肖庆, 丰伟, 田新华. 椎-基底动脉夹层动脉瘤介入治疗的疗效分析[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 350-358.
[11] 张文胜, 幸伟芳, 谢颖, 何锦照. 急性前循环大血管闭塞血管内治疗头颅CT高密度影的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(02): 159-162.
[12] 黎丹丹, 程峙娟, 刘旭, 陈未平, 殷敏, 郭华, 涂江龙. 急性后循环进展性缺血性卒中患者血管内治疗的效果[J]. 中华脑血管病杂志(电子版), 2023, 17(02): 112-123.
[13] 曹杨, 张凯, 张士永. 低NIHSS评分伴大血管闭塞性急性缺血性卒中机械取栓治疗效果分析[J]. 中华脑血管病杂志(电子版), 2023, 17(02): 107-111.
[14] 张运, 裴月红, 傅瑜. 急性缺血性卒中静脉溶栓治疗进展[J]. 中华脑血管病杂志(电子版), 2023, 17(02): 83-88.
[15] 钱锦宏, 吴建东, 丁志良, 董晓峰, 唐晓宇, 马冕, 邓朋. 慢性症状性颈内动脉闭塞开通的初步探索[J]. 中华脑血管病杂志(电子版), 2022, 16(06): 416-421.
阅读次数
全文


摘要